Louise Pemberton

1.2k total citations
26 papers, 990 citations indexed

About

Louise Pemberton is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Louise Pemberton has authored 26 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 6 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Louise Pemberton's work include HIV Research and Treatment (14 papers), HIV-related health complications and treatments (6 papers) and Alzheimer's disease research and treatments (5 papers). Louise Pemberton is often cited by papers focused on HIV Research and Treatment (14 papers), HIV-related health complications and treatments (6 papers) and Alzheimer's disease research and treatments (5 papers). Louise Pemberton collaborates with scholars based in Australia, United States and South Korea. Louise Pemberton's co-authors include Bruce J. Brew, Stephen J. Kerr, Matthew Law, Philip Cunningham, George A. Smythe, Kaj Blennow, Anders Wallin, Lars Hagberg, John Kaldor and Nancy M. Dunbar and has published in prestigious journals such as Neurology, The Journal of Infectious Diseases and Journal of Leukocyte Biology.

In The Last Decade

Louise Pemberton

24 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Louise Pemberton Australia 12 591 312 279 230 216 26 990
Sandra Suárez France 13 161 0.3× 106 0.3× 87 0.3× 88 0.4× 87 0.4× 22 558
Frances W. Carnie United Kingdom 7 390 0.7× 204 0.7× 77 0.3× 152 0.7× 188 0.9× 7 647
Valerie Wojna Puerto Rico 17 614 1.0× 228 0.7× 135 0.5× 235 1.0× 252 1.2× 45 960
Stephanie D. Kraft-Terry United States 9 296 0.5× 100 0.3× 93 0.3× 114 0.5× 159 0.7× 10 642
Wilmar Dumaop United States 12 514 0.9× 161 0.5× 72 0.3× 144 0.6× 243 1.1× 13 1.1k
Ned Sacktor United States 12 389 0.7× 215 0.7× 52 0.2× 211 0.9× 90 0.4× 19 554
Ken Vaca United States 7 333 0.6× 98 0.3× 74 0.3× 45 0.2× 299 1.4× 8 711
Joshua G. Lisinicchia United States 9 344 0.6× 152 0.5× 35 0.1× 90 0.4× 185 0.9× 13 649
Mitchel Morey United States 8 513 0.9× 135 0.4× 64 0.2× 123 0.5× 278 1.3× 12 750
E.M.E. Burudi United States 8 184 0.3× 73 0.2× 83 0.3× 28 0.1× 166 0.8× 10 430

Countries citing papers authored by Louise Pemberton

Since Specialization
Citations

This map shows the geographic impact of Louise Pemberton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise Pemberton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise Pemberton more than expected).

Fields of papers citing papers by Louise Pemberton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise Pemberton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise Pemberton. The network helps show where Louise Pemberton may publish in the future.

Co-authorship network of co-authors of Louise Pemberton

This figure shows the co-authorship network connecting the top 25 collaborators of Louise Pemberton. A scholar is included among the top collaborators of Louise Pemberton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise Pemberton. Louise Pemberton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pemberton, Louise, et al.. (2019). Preparing for anatomy assessment with adaptive learning resources – It is going “tibia” okay!. Charles Sturt University Research Output (CRO). 2 indexed citations
2.
3.
Linden, Kelly, et al.. (2018). Can we calm first-year student’s “neuroscience anxiety” with adaptive learning resources?. ASCILITE Publications. 451–455. 1 indexed citations
4.
Warne, Mark & Louise Pemberton. (2009). Informatics in Compound Library Management. Methods in molecular biology. 565. 55–68. 1 indexed citations
5.
Pemberton, Louise, Emma Stone, Patricia Price, Frank van Bockxmeer, & Bruce J. Brew. (2008). The relationship betweenApoE, TNFA, IL1a, IL1bandIL12bgenes and HIV‐1‐associated dementia. HIV Medicine. 9(8). 677–680. 34 indexed citations
6.
Pierik, Antonio J., et al.. (2008). But‐3‐ene‐1,2‐diol: A Mechanism‐Based Active Site Inhibitor for Coenzyme B12‐Dependent Glycerol Dehydratase. ChemBioChem. 9(14). 2268–2275. 7 indexed citations
7.
Brew, Bruce J., Louise Pemberton, Kaj Blennow, Anders Wallin, & Lars Hagberg. (2005). CSF amyloid β42 and tau levels correlate with AIDS dementia complex. Neurology. 65(9). 1490–1492. 148 indexed citations
8.
Brew, Bruce J., Louise Pemberton, & John E. Ray. (2004). Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs?. Journal of NeuroVirology. 10(1). 38–43. 4 indexed citations
9.
Brew, Bruce J., Louise Pemberton, & John E. Ray. (2004). Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs?. Journal of NeuroVirology. 10(0). 38–43. 6 indexed citations
10.
Guillemin, Gilles J., Stephen J. Kerr, Louise Pemberton, et al.. (2001). IFN- β 1b Induces Kynurenine Pathway Metabolism in Human Macrophages: Potential Implications for Multiple Sclerosis Treatment. Journal of Interferon & Cytokine Research. 21(12). 1097–1101. 75 indexed citations
11.
Pemberton, Louise & Bruce J. Brew. (2001). Cerebrospinal fluid S-100β and its relationship with AIDS dementia complex. Journal of Clinical Virology. 22(3). 249–253. 42 indexed citations
12.
McPhee, Dale A., Alison L. Greenway, Gavan Holloway, et al.. (1998). Anomalies in Nef expression within the central nervous system of HIV-1 positive individuals/AIDS patients with or without AIDS dementia complex. Journal of NeuroVirology. 4(3). 291–300. 11 indexed citations
13.
Brew, Bruce J., Louise Pemberton, Philip Cunningham, & Matthew Law. (1997). Levels of Human Immunodeficiency Virus Type 1 RNA in Cerebrospinal Fluid Correlate with AIDS Dementia Stage. The Journal of Infectious Diseases. 175(4). 963–966. 184 indexed citations
14.
Pemberton, Louise, Stephen J. Kerr, George A. Smythe, & Bruce J. Brew. (1997). Quinolinic Acid Production by Macrophages Stimulated with IFN-γ, TNF-α, and IFN-α. Journal of Interferon & Cytokine Research. 17(10). 589–595. 128 indexed citations
15.
Cunningham, Anthony L., Hassan M. Naif, Nitin K. Saksena, et al.. (1997). HIV infection of macrophages and pathogenesis of AIDS dementia complex: interaction of the host cell and viral genotype. Journal of Leukocyte Biology. 62(1). 117–125. 44 indexed citations
16.
Kerr, Stephen J., et al.. (1997). Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages. Neurology. 49(6). 1671–1681. 75 indexed citations
17.
18.
Brew, Bruce J., Nancy M. Dunbar, Louise Pemberton, & John Kaldor. (1996). Predictive Markers of AIDS Dementia Complex: CD4 Cell Count and Cerebrospinal Fluid Concentrations of  2-Microglobulin and Neopterin. The Journal of Infectious Diseases. 174(2). 294–298. 99 indexed citations
19.
Brew, Bruce J., Jacques Corbeil, Louise Pemberton, et al.. (1995). Quinolinic acid production is related to macrophage tropic isolates of HIV-1. Journal of NeuroVirology. 1(5-6). 369–374. 42 indexed citations
20.
Pemberton, Louise. (1965). THE AMENITY VALUE OF TREES. 1(1). 17–19. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra Suárez Breakdown of academic impact, for papers by Frances W. Carnie Breakdown of academic impact, for papers by Valerie Wojna Breakdown of academic impact, for papers by Stephanie D. Kraft-Terry Breakdown of academic impact, for papers by Wilmar Dumaop Breakdown of academic impact, for papers by Ned Sacktor Breakdown of academic impact, for papers by Ken Vaca Breakdown of academic impact, for papers by Joshua G. Lisinicchia Breakdown of academic impact, for papers by Mitchel Morey Breakdown of academic impact, for papers by E.M.E. Burudi
Rankless by CCL
2026